Editorial 男性優位なバイオ業界 2015年8月1日 Nature Biotechnology 33, 8 doi: 10.1038/nbt.3308 No matter where you look in biopharmaceutical boardrooms, gender bias is evident. Is it so difficult to actually acknowledge this pernicious bias and actively discourage all-male boards? Full text PDF 目次へ戻る
